Biomarkers in predicting mortality from cardiovascular events in patients with heart failure and an implanted cardioverter-defibrillator

Aim. To study the role of blood biomarkers in predicting death from cardiovascular events in patients with heart failure with reduced ejection fraction (HFrEF) within one year after cardioverter defibrillator (ICD) implantation.Material and methods. This one-center observation study included 384 HFr...

Full description

Bibliographic Details
Published in:	Рациональная фармакотерапия в кардиологии
Main Authors:	N. N. Ilov, O. V. Petrova, D. K. Tverdokhlebova, I. R. Karimov, A. A. Nechepurenko, S. A. Boytsov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2023-10-01
Subjects:	heart failure mortality from cardiovascular events biomarkers prognosis cardioverter-defibrillator.
Online Access:	https://www.rpcardio.online/jour/article/view/2938

Similar Items

Prediction of early mortality after cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: focus on transthoracic echocardiography
by: N. N. Ilov, et al.
Published: (2023-07-01)

Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

Psychological Problems of Patients with Implantable Cardioverter Defibrillators in Baghdad City.
by: Bayda'a A. Kareem
Published: (2014-04-01)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
by: Temirkhan Begisbayev, et al.
Published: (2022-05-01)

Incidence, Predictors, and Outcomes of Implantable Cardioverter‐Defibrillator Discharge Among People Living With HIV
by: Raza M. Alvi, et al.
Published: (2018-09-01)

Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience
by: Paola Ferrari, MD, et al.
Published: (2016-06-01)

Underrepresentation of women in implantable cardioverter defibrillator trials
by: Janet K. Han, et al.
Published: (2022-02-01)

An unusual cause of implantable cardioverter defibrillator malfunction: Twiddler syndrome
by: Ufuk Eryılmaz, et al.
Published: (2013-10-01)

Long‐term safety and efficacy of subcutaneous implantable cardioverter‐defibrillator compared with transvenous implantable cardioverter‐defibrillator in propensity score‐matched patients from Japan
by: Yuki Konno, et al.
Published: (2025-04-01)

Prognostic comparison between implantable cardioverter‐defibrillator and amiodarone in cancer patients
by: Hirota Kida, et al.
Published: (2025-06-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01)

Implantable cardioverter defibrillators for primary prevention in cardiomyopathies
by: Vineetha Kanneganti, et al.
Published: (2024-03-01)

Epicardial cardioverter defibrillator implantation due to post-fontan ventricular tachycardia
by: Nikolaos A Papakonstantinou, et al.
Published: (2020-01-01)

Short-term Venous Patency after Implantation of Permanent Pacemakers or Implantable Cardioverter Defibrillators
by: Takeshi Nakae, MD, et al.
Published: (2010-01-01)

Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria
by: Yoshimori An, MD, et al.
Published: (2017-02-01)

Use of the wearable cardioverter-defibrillator – the Swiss experience
by: Boldizsar Kovacs, et al.
Published: (2020-09-01)

Patient characteristics and in‐hospital complications of subcutaneous implantable cardioverter‐defibrillator for Brugada syndrome in Japan
by: Iwanari Kawamura, et al.
Published: (2019-12-01)

Predictors of Mortality Amongst Recipients of Implantable Cardioverter Defibrillators for Secondary Prevention of Cardiac Arrest
by: Sunil K. Agarwal, et al.
Published: (2007-10-01)

T-Wave Oversensing with Contemporary Implantable Cardioverter–Defibrillators
by: Marc Strik, et al.
Published: (2023-10-01)

Patients’ Knowledge about Safe Measures Post Implantable Cardioverter Defibrillator
by: Mohammed Kadhum Sadaq, et al.
Published: (2025-09-01)

Sudden Death Due to Thrombosis Associated with Implantable Cardioverter-Defibrillator Electrodes
by: Jose Maria Frutos Perez, et al.
Published: (2021-03-01)

Adaptation status and related factors in patients living with implantable cardioverter defibrillators
by: Mohammadreza Razavi, et al.
Published: (2022-01-01)

Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter‐Defibrillator Systems—A Simple Issue?
by: Gerrit Frommeyer, et al.
Published: (2016-03-01)

Quality of Life and Psychological Factors in Patients with Implantable Cardioverter Defibrillator
by: Akiko Suyama-Chishaki, MD PhD, et al.
Published: (2007-01-01)

Subcutaneous implantable cardioverter defibrillator: Where do we stand?
by: Arindam Pande, et al.
Published: (2016-01-01)

Long-term clinical outcomes in implantable cardioverter defibrillator recipients on the island of Crete
by: Emmanuel M. Kanoupakis, et al.
Published: (2016-07-01)

Shoulder Joint Dislocation as an Unusual Complication of Defibrillation Threshold Testing Following Subcutaneous Implantable Cardioverter-Defibrillator Implantation
by: Amit Noheria, MBBS, SM, et al.
Published: (2014-11-01)

Psychological distress in patients with an implantable cardioverter defibrillator
by: Tsuyoshi Shiga, et al.
Published: (2013-12-01)

Factors associated with the risk of progression and decompensation of heart failure in patients with an implantable cardioverter-defibrillator
by: N. B. Lebedeva, et al.
Published: (2024-04-01)

“Real-world” analysis of battery longevity of implantable cardioverter-defibrillators: an in-depth analysis of a prospective defibrillator database
by: Diogo de Almeida Fernandes, et al.
Published: (2023-12-01)

Relation of Supraventricular Arrhythmias Detected by Implantable Cardioverter Defibrillator and Air Pollutants
by: Javad Shahabi, et al.
Published: (2024-08-01)

The effect of air pollution on ventricular arrhythmias in patients with implantable cardioverter defibrillator
by: Javad Shahabi, et al.
Published: (2023-01-01)

The contribution of implantable cardioverter defibrillators to systemic inflammation in heart failure patients
by: Ozcan Orscelik, et al.
Published: (2019-06-01)

New old life of patients after implantation of implantable cardioverter-defibrillator
by: Monika Paleczna
Published: (2023-09-01)

Survival Following Implantable Cardioverter‐Defibrillator Implantation in Patients With Amyloid Cardiomyopathy
by: Angela Y. Higgins, et al.
Published: (2020-09-01)

Air entrapment causing ventricular oversensing early after implantation of an extravascular implantable cardioverter-defibrillator
by: Julia Hermes, MD, et al.
Published: (2024-09-01)

Interval training effects in patients with implantable cardioverter defibrillator depending on their exercise tolerance level
by: Kamila Bielecka-Kowal, et al.
Published: (2020-03-01)

Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland
by: Boldizsar Kovacs, et al.
Published: (2019-11-01)